Department of Biological Sciences, University of Notre Dame , Notre Dame, Indiana, USA.
Eck Institute for Global Health, University of Note Dame , Notre Dame, Indiana, USA.
mBio. 2023 Oct 31;14(5):e0098723. doi: 10.1128/mbio.00987-23. Epub 2023 Sep 29.
N-terminal acetylation is a protein modification that broadly impacts basic cellular function and disease in higher organisms. Although bacterial proteins are N-terminally acetylated, little is understood how N-terminal acetylation impacts bacterial physiology and pathogenesis. Mycobacterial pathogens cause acute and chronic disease in humans and in animals. Approximately 15% of mycobacterial proteins are N-terminally acetylated, but the responsible enzymes are largely unknown. We identified a conserved mycobacterial protein required for the N-terminal acetylation of 23 mycobacterial proteins including the EsxA virulence factor. Loss of this enzyme from reduced macrophage killing and spread of to new host cells. Defining the acetyltransferases responsible for the N-terminal protein acetylation of essential virulence factors could lead to new targets for therapeutics against mycobacteria.
N-端乙酰化是一种广泛影响高等生物基本细胞功能和疾病的蛋白质修饰。尽管细菌蛋白被 N-端乙酰化,但对于 N-端乙酰化如何影响细菌生理学和发病机制知之甚少。分枝杆菌病原体在人类和动物中引起急性和慢性疾病。大约 15%的分枝杆菌蛋白被 N-端乙酰化,但负责的酶在很大程度上是未知的。我们鉴定了一种保守的分枝杆菌蛋白,该蛋白是 23 种分枝杆菌蛋白(包括 EsxA 毒力因子)N-端乙酰化所必需的。从 中缺失这种酶会减少巨噬细胞的杀伤作用,并导致 向新宿主细胞的传播。确定负责必需毒力因子 N-端蛋白质乙酰化的乙酰转移酶,可能会为针对分枝杆菌的治疗方法提供新的靶点。